PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Replimune Group, Inc. (REPL)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US76029N1063

CUSIP

76029N106

Sector

Healthcare

IPO Date

Jul 20, 2018

Highlights

Market Cap

$1.06B

EPS (TTM)

-$3.07

Total Revenue (TTM)

$4.04M

Gross Profit (TTM)

$2.65M

EBITDA (TTM)

-$217.67M

Year Range

$4.92 - $17.00

Target Price

$20.88

Short %

15.18%

Short Ratio

9.80

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Replimune Group, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%10.00%20.00%30.00%40.00%50.00%SeptemberOctoberNovemberDecember2025February
34.19%
9.31%
REPL (Replimune Group, Inc.)
Benchmark (^GSPC)

Returns By Period

Replimune Group, Inc. had a return of 13.79% year-to-date (YTD) and 80.13% in the last 12 months.


REPL

YTD

13.79%

1M

35.90%

6M

34.18%

1Y

80.13%

5Y*

-3.63%

10Y*

N/A

^GSPC (Benchmark)

YTD

4.46%

1M

2.46%

6M

9.31%

1Y

23.49%

5Y*

13.03%

10Y*

11.31%

*Annualized

Monthly Returns

The table below presents the monthly returns of REPL, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202515.44%13.79%
2024-7.95%10.57%-4.78%-22.28%-17.01%70.78%11.11%1.70%7.77%7.30%19.73%-13.99%43.65%
20232.39%-21.36%-19.36%-5.27%13.51%22.27%-9.26%-3.08%-16.21%-14.85%-23.27%-24.60%-69.01%
2022-26.83%-19.11%5.86%-1.24%-13.36%20.30%10.30%-1.14%-9.39%6.31%11.49%32.88%0.37%
20211.70%-10.75%-11.90%19.93%6.50%-1.41%-14.81%-2.96%-6.68%-0.44%-3.46%-4.88%-28.96%
202010.80%-12.77%-28.12%81.44%3.81%32.32%-19.64%35.20%-14.74%81.62%23.61%-26.18%165.85%
201921.10%13.29%10.93%10.18%-19.38%8.43%-15.28%-16.43%33.91%22.30%-18.24%3.24%43.50%
2018-1.12%28.69%-16.54%-20.00%16.38%-33.29%-34.04%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 78, REPL is among the top 22% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of REPL is 7878
Overall Rank
The Sharpe Ratio Rank of REPL is 7878
Sharpe Ratio Rank
The Sortino Ratio Rank of REPL is 8181
Sortino Ratio Rank
The Omega Ratio Rank of REPL is 7575
Omega Ratio Rank
The Calmar Ratio Rank of REPL is 7676
Calmar Ratio Rank
The Martin Ratio Rank of REPL is 8181
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Replimune Group, Inc. (REPL) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for REPL, currently valued at 1.02, compared to the broader market-2.000.002.001.021.74
The chart of Sortino ratio for REPL, currently valued at 2.08, compared to the broader market-4.00-2.000.002.004.006.002.082.35
The chart of Omega ratio for REPL, currently valued at 1.24, compared to the broader market0.501.001.502.001.241.32
The chart of Calmar ratio for REPL, currently valued at 0.88, compared to the broader market0.002.004.006.000.882.61
The chart of Martin ratio for REPL, currently valued at 4.98, compared to the broader market0.0010.0020.0030.004.9810.66
REPL
^GSPC

The current Replimune Group, Inc. Sharpe ratio is 1.02. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Replimune Group, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
1.02
1.74
REPL (Replimune Group, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Replimune Group, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-73.83%
0
REPL (Replimune Group, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Replimune Group, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Replimune Group, Inc. was 90.48%, occurring on May 29, 2024. The portfolio has not yet recovered.

The current Replimune Group, Inc. drawdown is 73.83%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-90.48%Dec 2, 2020877May 29, 2024
-59.8%Sep 5, 2018389Mar 23, 202051Jun 4, 2020440
-27.36%Jun 26, 202022Jul 28, 202023Aug 28, 202045
-23.56%Sep 1, 202017Sep 24, 202014Oct 14, 202031
-15.89%Jun 9, 20201Jun 9, 202012Jun 25, 202013

Volatility

Volatility Chart

The current Replimune Group, Inc. volatility is 22.08%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%SeptemberOctoberNovemberDecember2025February
22.08%
3.07%
REPL (Replimune Group, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Replimune Group, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Replimune Group, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab